Need professional-grade analysis? Visit stockanalysis.com
$601.87M
N/A
174
N/A
Anteris Technologies Global Corp. Common Stock (AVR) trades on United States in USD. The company is classified in the Healthcare sector under the Medical Instruments & Supplies industry. The stock currently trades at $5.70, down 6.10% from the previous close.
Over the past year, AVR has traded between a low of $2.90 and a high of $6.69. The stock has gained 27.2% over this period. It is currently 14.8% below its 52-week high.
Anteris Technologies Global Corp. Common Stock has a market capitalization of $601.87M.
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.
Side-by-side comparison against top Healthcare peers.